Kidswell Bio CorporationTSE 4584
キッズウェル・バイオ株式会社 · Pharmaceutical · FY ends Mar
Share price at FY-end
—
FY ending Mar 2026
Avg. director pay
¥24.7M
Internal directors
Top 10 shareholders
| # | Shareholder | Shares | Stake | Value | Dividends |
|---|
| 1 |
ノーリツ鋼機株式会社
|
9,471,832 |
19.08% |
— |
— |
| 2 |
江平 文茂
|
2,000,000 |
4.03% |
— |
— |
| 3 |
NANO ホールディングス株式会社
|
1,000,000 |
2.01% |
— |
— |
| 4 |
楽天証券株式会社共有口
|
792,600 |
1.59% |
— |
— |
| 5 |
千寿製薬株式会社
|
555,200 |
1.11% |
— |
— |
| 6 |
野村信託銀行株式会社
|
471,000 |
0.94% |
— |
— |
| 7 |
北島 義彦
|
445,000 |
0.89% |
— |
— |
| 8 |
BNY GCM CLIENT ACCOUNT JPRD AC ISG
|
440,600 |
0.88% |
— |
— |
| 9 |
津田 謹誠
|
436,800 |
0.88% |
— |
— |
| 10 |
大友 宏一
|
400,050 |
0.80% |
— |
— |
Officers' holdings and pay
| Name | Title | Shares | Value | Pay |
|---|
| 紅林 伸也 |
President & Representative Director |
91,000 |
— |
— |
| 栄木 憲和 |
Director |
— |
— |
— |
| 西岡 佐知子 |
Director |
— |
— |
— |
| 菅原 治 |
Full-time Audit & Supervisory Board Member |
6,200 |
— |
— |
| 森 正人 |
Audit & Supervisory Board Member |
2,300 |
— |
— |
| 品川 広志 |
Audit & Supervisory Board Member |
23,100 |
— |
— |
Pay is shown only for officers whose pay of ¥100 million or more is disclosed individually.
Per-share data by fiscal year
| Fiscal year | Price | EPS | P/E | Dividend | Shares issued |
|---|
| FY ending Mar 2026 |
— |
¥-8.48 |
41.2x |
— |
49,623,419 |
| FY ending Mar 2025 |
— |
¥-0.52 |
7.9x |
— |
43,881,013 |
| FY ending Mar 2024 |
— |
¥-40.23 |
— |
— |
38,939,913 |
| FY ending Mar 2023 |
— |
¥-20.77 |
— |
— |
32,059,713 |
| FY ending Mar 2022 |
— |
¥-17.35 |
— |
— |
31,437,547 |
| FY ending Mar 2021 |
— |
¥-34.79 |
— |
— |
29,622,847 |
| FY ending Mar 2020 |
— |
¥-264.65 |
— |
— |
27,646,986 |
| FY ending Mar 2019 |
— |
¥-43.84 |
— |
— |
20,342,446 |
| FY ending Mar 2018 |
— |
¥-94.54 |
— |
— |
9,567,923 |
| FY ending Mar 2017 |
— |
¥-137.01 |
— |
— |
9,567,923 |
Source: annual securities reports on EDINET. Values are estimates.
Methodology